Table 1.

Baseline characteristics and clinical outcome of patients

CharacteristicValue
Patients98
Age (yr)
    mean ± SD34 ± 13
    range12 to 64
Male gender (%)45
BMI (kg/m2)
    mean ± SD21.8 ± 2.9
    range15.5 to 31.6
eGFR (ml/min per 1.73 m2)
    mean ± SD87 ± 18
    range61 to 132
Hypertension (%)23
Urinary protein excretion (g/d)
    mean ± SD1.10 ± 1.10
    range0.05 to 7.60
Length of follow-up (yr)
    mean ± SD11.0 ± 5.2
    range2.5 to 34.0
Corticosteroid treatment (%)28
ACEI or ARB treatment (%)71
Urinary protein excretion at the
final (g/d)
    mean ± SD0.90 ± 1.40
    range0.02 to 9.80
Changes of eGFR (%/yr)
    mean ± SD−3.0 ± 3.3
    range−19.8 to 2.5
>50% reduction in eGFR (%)18
ESRD (%)7
  • ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BMI, body mass index.